| Generic/working name | Bimiralisib |
| Company name | PIQUR Therapeutics AG (Basel, Switzerland) |
| Drug type | Small molecule |
| Drug class | PI3K/mTOR |
| Dose | 140 |
| Unit | Mg |
| Route | Oral |
| Schedule of administration | Daily on 2 consecutive days weekly |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.